Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966
Abstract Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to significant morbidity or mortality. In...
Main Authors: | Christina Bergqvist, Amandine Servy, Laurence Valeyrie-Allanore, Salah Ferkal, Patrick Combemale, Pierre Wolkenstein, NF France Network |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-020-1310-3 |
Similar Items
-
Neurofibromatosis I and multiple sclerosis
by: Christina Bergqvist, et al.
Published: (2020-07-01) -
Lymphoproliferative malignancies in patients with neurofibromatosis 1
by: Christina Bergqvist, et al.
Published: (2021-05-01) -
Establishing the diagnosis neurofibromatosis type 1: A rare case
by: Dyatiara Devy, et al.
Published: (2019-04-01) -
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study
by: Sbidian Emilie, et al.
Published: (2012-09-01) -
Segmental Neurofibromatosis
by: Dimble Raju, et al.
Published: (2021-01-01)